Hiroki Yoneyama
Osaka University of Pharmaceutical Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroki Yoneyama.
Bioorganic & Medicinal Chemistry Letters | 2013
Shinya Harusawa; Koichi Sawada; Takuji Magata; Hiroki Yoneyama; Lisa Araki; Yoshihide Usami; Kouta Hatano; Kouichi Yamamoto; Daisuke Yamamoto; Atsushi Yamatodani
S-Alkyl-N-alkylisothiourea compounds containing various cyclic amines were synthesized in the search for novel nonimidazole histamine H3 receptor (H3R) antagonists. Among them, four N-alkyl S-[3-(piperidin-1-yl)propyl]isothioureas 18, 19, 22, and 23 were found to exhibit potent and selective H3R antagonistic activities against in vitro human H3R, but were inactive against in vitro human H4R. Furthermore, three alkyl homologs 18-20 showed inactivity for histamine release in in vivo rat brain microdialysis, suggesting differences in antagonist affinities between species. In addition, in silico docking studies of N-[4-(4-chlorophenyl)butyl]-S-[3-piperidin-1-yl)propyl]isothiourea 19 and a shorter homolog 17 with human/rat H3Rs revealed that structural differences between the antagonist-docking cavities of rat and human H3Rs were likely caused by the Ala122/Val122 mutation.
Journal of Organic Chemistry | 2008
Hiroki Yoneyama; Ayako Shimoda; Lisa Araki; Kouta Hatano; Yasuhiko Sakamoto; Takushi Kurihara; Atsushi Yamatodani; Shinya Harusawa
S-Alkyl-N-alkylisothioureas were efficiently synthesized via synthetic approach (A) using 3-phenylpropionyl isothiocyanate (PPI). The utility of the approach was proved by the syntheses of clobenpropit, a potent histamine H(3) antagonist, and its analogues. Alternatively, clobenpropit could be prepared via intramolecular amide cleavage (B) with use of 2-nitrophenylacetyl isothiocyanate (NPAI).
Journal of Organic Chemistry | 2017
Hiroki Yoneyama; Masahiro Numata; Kenji Uemura; Yoshihide Usami; Shinya Harusawa
Cyanophosphates (CPs) can be easily prepared from either ketones or aldehydes, and their reaction with NaN3-Et3N·HCl results in the formation of azidotetrazoles. Under microwave irradiation, successive fragmentation of the azidotetrazoles generates alkylidene carbenes that undergo [1,2]-rearrangement and are transformed into homologous alkynes. Treatment of ketone-derived CPs with TMSN3 and Bu2SnO as catalyst in toluene at reflux directly yields the corresponding internal alkynes, whereas the reaction of aldehyde-derived CPs with NaN3-Et3N·HCl in THF at reflux or TMSN3-Bu2SnO (cat.) in toluene at reflux provides homologous terminal alkynes in good yields. These reactions take place under neutral conditions and can be successfully extended to obtain alkynes that are not usually accessible from the corresponding carbonyl compounds by the Ohira-Bestmann or Shioiri procedures, which require basic conditions.
Inorganic Chemistry | 2017
Seiji Komeda; Hiroki Yoneyama; Masako Uemura; Akira Muramatsu; Naoto Okamoto; Hiroaki Konishi; Hiroyuki Takahashi; Akimitsu Takagi; Wakao Fukuda; Tadayuki Imanaka; Toshio Kanbe; Shinya Harusawa; Yuko Yoshikawa; Kenichi Yoshikawa
Derivatives of the highly antitumor-active compound [{cis-Pt(NH3)2}2(μ-OH)(μ-tetrazolato-N2,N3)]2+ (5-H-Y), which is a tetrazolato-bridged dinuclear platinum(II) complex, were prepared by substituting a linear alkyl chain moiety at C5 of the tetrazolate ring. The general formula for the derivatives is [{cis-Pt(NH3)2}2(μ-OH)(μ-5-R-tetrazolato-N2,N3)]2+, where R is (CH2)nCH3 and n = 0 to 8 (complexes 1-9). The cytotoxicity of complexes 1-4 in NCI-H460 human non-small-cell lung cancer cells decreased with increasing alkyl chain length, and those of complexes 5-9 increased with increasing alkyl chain length. That is, the in vitro cytotoxicity of complexes 1-9 was found to have a U-shaped association with alkyl chain length. This U-shaped association is attributable to the degree of intracellular accumulation. Although circular dichroism spectroscopic measurement indicated that complexes 1-9 induced comparable conformational changes in the secondary structure of DNA, the tetrazolato-bridged complexes induced different degrees of DNA compaction as revealed by a single DNA measurement with fluorescence microsopy, which also had a U-shaped association with alkyl chain length that matched the association observed for cytotoxicity. Complexes 7-9, which had alkyl chains long enough to confer surfactant-like properties to the complex, induced DNA compaction 20 or 1000 times more efficiently than 5-H-Y or spermidine. A single DNA measurement with transmission electron microscopy revealed that complex 8 formed large spherical self-assembled structures that induced DNA compaction with extremely high efficiency. This result suggests that these structures may play a role in the DNA compaction that was induced by the complexes with the longer alkyl chains. The derivatization with a linear alkyl chain produced a series of complexes with unique cellular accumulation and DNA conformational change profiles and a potentially useful means of developing next-generation platinum-based anticancer drugs. In addition, the markedly high ability of these complexes to induce DNA compaction and their high intracellular accumulation emphasized the difference in mechanism of action from platinum-based anticancer drugs.
Heterocycles | 2018
Shinya Harusawa; Hiroki Yoneyama; Fumiko Hikasa; Daiki Fujisue; Yoshihide Usami; Zheng-yun Zhao
Novel C4-linked triazol C0-, C1and C2-ribonucleoside phosphoramidites for RNA catalysis probing were synthesized from β-ribofuranosyl-Cn-acetylenes (n = 0–2), which were efficiently prepared by fragmentation of tetrazoles derived from cyanophosphates. N-Pivaloyloxymethyl moiety was selected for the protection of triazole-N, whose properties under acidic and basic conditions were investigated. INTRODUCTION We have recently reported the efficient synthesis of C4-linked C0to C3-imidazole ribonucleoside phosphoramidites [Imz-Cn-PAs (1a–d)], which could be introduced in RNA using solid-phase t-BDMS chemistry implemented on an automated synthesizer, as shown in Figure 1.1 During the synthesis of these phosphoramidites, pivaloyloxymethyl (POM)1b and cyanoethyl (CE)1c groups were employed successfully as suitable protecting groups for the imidazole -nitrogen and sugar 2’-hydroxy functions, respectively. Since imidazoles (pKa of 14.2) are both good proton donors and acceptors,2 we developed a novel chemogenetic approach using Imz-Cn-PAs 1 for the study of the catalytic mechanism of Varkud satellite (VS)3a and hairpin ribozymes,3b where conventional nucleobases are replaced by imidazoles as a powerful tool to probe general acid–base catalysis in the active sites of ribozymes.4 The results from this approach indicated that the chemical mechanisms of VS and hairpin ribozymes involve general acid–base catalysis via a combination of specific adenine (A) and guanine (G) nucleobases (e.g., A756 and G638 in 106 HETEROCYCLES, Vol. 96, No. 1, 2018
Molecules | 2018
Yoshihide Usami; Aoi Kohno; Hiroki Yoneyama; Shinya Harusawa
Synthesis of novel pyrazole-fused heterocycles, i.e., dihydro-1H- or 2H-oxepino[3,2-c]pyrazoles (6 or 7) from 4-allyloxy-1H-pyrazoles (1) via combination of Claisen rearrangement and ring-closing metathesis (RCM) has been achieved. A suitable catalyst for the RCM of 5-allyl-4-allyloxy-1H-pyrazoles (4) was proved to be the Grubbs second generation catalyst (Grubbs2nd) to give the predicted RCM product at room temperature in three hours. The same reactions of the regioisomer, 3-allyl-4-allyloxy-1H-pyrazoles (5), also proceeded to give the corresponding RCM products. On the other hand, microwave aided RCM at 140 °C on both of 4 and 5 afforded mixtures of isomeric products with double bond rearrangement from normal RCM products in spite of remarkable reduction of the reaction time to 10 min.
Marine Drugs | 2017
Yoshihide Usami; Koji Mizuki; Rikiya Kawahata; Makio Shibano; Atsuko Sekine; Hiroki Yoneyama; Shinya Harusawa
Pericosine E (6), a metabolite of Periconia byssoides OUPS-N133 was originally isolated from the sea hare Aplysia kurodai, which exists as an enantiomeric mixture in nature. The enantiospecific syntheses of both enantiomers of Periconia byssoides OUPS-N133 has been achieved, along with six stereoisomers, using a common simple synthetic strategy. For these efficient syntheses, highly regio- and steroselective processes for the preparation of bromohydrin and anti-epoxide intermediates were applied. In order to access the unique O-linked carbadisaccharide structure, coupling of chlorohydrin as a donor and anti-epoxide as an acceptor was achieved using catalytic BF3·Et2O. Most of the synthesized compounds exhibited selectively significant inhibitory activity against α-glycosidase derived from yeast. The strongest analog showed almost 50 times the activity of the positive control, deoxynojirimycin.
Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2016
Hiroki Yoneyama; Daisuke Yamamoto; Atsushi Yamatodani; Shinya Harusawa
S-Alkyl-N-alkylisothiourea compounds, which contain various cyclic amines, were synthesized using 3-phenylpropionyl isothiocyanate (PPI) to discover novel non-imidazole histamine H3 receptor (H3R) antagonists. The synthetic route was improved remarkably by using 2-nitrophenylacetyl isothiocyanate (NPAI). Among the synthesized compounds, N-[4-(4-chlorophenyl)butyl]-S-[3-piperidin-1-yl)propyl]isothiourea (1k, OUP-186) exhibited potent and selective antagonism against human H3R but not human H4R, in vitro. Of particular interest, they did not show antagonism for the histamine release in rat brain microdialysis in vivo, suggesting species-selective differences in antagonist affinities. Furthermore, in silico docking studies of OUP-186 and its C2-homolog (OUP-181) in human/rat H3Rs suggested that the structural difference of antagonist-docking sites between human and rat H3Rs was attributable to the Ala122/Val122 mutation.
Synthesis | 2013
Hiroki Yoneyama; Yoshihide Usami; Seiji Komeda; Shinya Harusawa
Tetrahedron Letters | 2012
Shinya Harusawa; Hiroki Yoneyama; Daiki Fujisue; Masayoshi Nishiura; Mihoyo Fujitake; Yoshihide Usami; Zheng-yun Zhao; Scott A. McPhee; Timothy J. Wilson; David M. J. Lilley